Breast cancer can be classified based on immunohistochemical markers such as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) (Xupeng et al., 2021). This evidence concerns the gene PGR and breast carcinoma.